First CAR T-Cell ‘Living Drug’ Approved by FDA – Medscape
Medscape |
First CAR T-Cell 'Living Drug' Approved by FDA
Medscape The first T–cell therapy that uses chimeric antigen receptor (CAR) technology has been approved today by the US Food and Drug Administration (FDA), paving the way for the other products using this novel approach that are in development. "We're entering … FDA approval brings first gene therapy to the United States Novartis receives first ever FDA approval for a CAR–T cell therapy, Kymriah(TM) (CTL019), for children and young … A cancer treatment that one expert called the 'most exciting thing I've seen in my lifetime' just got approved |
